Sun Pharma Advanced Research Company Ltd. — Proxy Solicitation & Information Statement 2026

Jan 29, 2026

January 29, 2026

SPARC/Sec/SE/2025-26/56

National Stock Exchange of India Ltd., Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051. Scrip Symbol: SPARC

BSE Limited,

Market Operations Dept. P. J. Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 532872

Dear Sir/ Madam,

Reference: Notice of Extra-Ordinary General Meeting of Sun Pharma Advanced Research Company Limited (“Company”) dated January 14, 2026 which was dispatched on January 16, 2026 (“EGM Notice”)

Sub: Corrigendum dated January 29, 2026 to the EGM Notice

In furtherance to our previous intimation dated January 16, 2026 in relation to issuing EGM Notice. The company has received few observations from National Stock Exchange of India Limited (“NSE”) vide their letter dated January 27, 2026, pursuant to and in response to the In-Principle Approval Application filed by our Company.

To address one of the observations of NSE, the Company has issued Corrigendum for providing additional clarity to the members of the Company. This Corrigendum to the EGM Notice shall form an integral part of the EGM Notice and from the date hereof, the EGM Notice shall always be read in conjunction with this Corrigendum.

All other contents of the EGM Notice, save and except as modified or supplemented by the Corrigendum, shall remain unchanged.

This Corrigendum shall be published in one English language newspaper and one Gujarati language newspaper having wide circulation in the district where the registered office of the Company is situated, namely Financial Express (English) and in Ahmedabad Edition (Gujarati Language) Financial Express on January 30, 2026. The Corrigendum shall also be made available on the websites of the stock exchanges, i.e. BSE Limited at www.bseindia.com and National Stock Exchange of India Limited at www.nseindia.com, as well as on the website of the Company at https://sparc.life/statutorydisclosures/shareholders-meeting/. Further, the Corrigendum is circulated to the members through electronic means, in the same manner as the EGM Notice, to ensure adequate dissemination of information prior to the commencement of e-voting.

This is for your information and record.

For Sun Pharma Advanced Research Company Ltd.

DamaniaKiran Kajal Digitally signed by Kajal Kiran DamaniaDN: C=IN, O=Personal, PostalCode=400050, S=Maharashtra, SERIALNUMBER=20771e9be78b61091f926f4b91c9856091372c5750bea467c18f3cb41af3da6b, CN=Kajal Kiran DamaniaReason: I am the author of this documentLocation: MahakaliDate: 2026.01.29 18:19:44+05'30'Foxit PDF Editor Version: 2024.3.0

Kajal Damania

Company Secretary and Compliance Officer

==> picture [80 x 35] intentionally omitted <==

SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED Corporate Identification Number: L73100GJ2006PLC047837

Registered Office: Plot No. 5 & 6/1, Savli G.I.D.C. Estate, Savli - Vadodara Highway, Manjusar, Vadodara - 391775, Gujarat, India. Website: www.sparc.life

CORRIGENDUM TO NOTICE OF EXTRA-ORDINARY GENERAL MEETING

This Corrigendum dated January 29, 2026 (“Corrigendum”) is issued in continuation of, and should be read together with, the Notice of Extra-Ordinary General Meeting (“EGM Notice”) dated January 14, 2026 which was dispatched on January 16, 2026 convening the EGM of the Sun Pharma Advanced Research Company Limited (“Company”) scheduled to be held on Monday, February 9, 2026 at 4:00 p.m. (IST) through Video Conferencing / Other Audio-Visual Means.

The Corrigendum is issued pursuant to observation received from National Stock Exchange of India Limited (“NSE”) vide its letter dated January 27, 2026 and for the purpose of providing additional clarity and disclosure to the Members.

Except as specifically stated herein, all other terms, information and resolutions contained in the EGM Notice remain unchanged.

(All capitalized words referred to herein shall have the same meaning as ascribed to it in EGM Notice.)

1. Clarification in relation to the equity share capital structure of the company:

Members are requested to refer to Paragraph 5 (Shareholding pattern of the Company before and after the Warrants Issue) of Item No. 1 of the Explanatory Statement to the EGM Notice.

Shareholding pattern of the Company before and after the Warrants Issue:

	(Data as on Wednesday, January 14, 2026)	(Data as on Wednesday, January 14, 2026)	(Data as on Wednesday, January 14, 2026)	(Data as on Wednesday, January 14, 2026)
Category of Shareholders	Pre-issue@		Post-Allotment#
	No. of Equity Shares	%	No. of Equity Shares	%
Promoter & Promoter Group ^
1. Indian
a. Individuals/HUF	6,54,40,885	20.17%	6,54,40,885	18.03%
b. Central / State Government	0	0.00%	0	0.00%
c. Financial Institutions/Banks	0	0.00%	0	0.00%
d. Bodies Corporate	13,72,17,968	42.28	17,57,27,968	48.40%
e. Promoters Trusts	1,54,922	0.05%	1,54,922	0.04%
f. Person Actingin Concert	1,03,01,320	3.17%	1,03,01,320	2.84%
2. Foreign	0	0.00%	0	0.00%

Page 1 of 3

Total Promoter/ Promoter Group (A)	21,31,15,095	65.67%	25,16,25,095	69.31%
Public Shareholders
1. Institutions	93,45,538	2.88%	93,45,538	2.58%
2. Central/State Government	668	0.00%	668	0.00%
3. Non-Institutions	10,20,60,287	31.45%	10,20,60,287	28.11%
Total Public Shareholding (B)	11,14,06,493	34.33%	11,14,06,493	30.69%
TOTAL(A+B)	32,45,21,588	100.00%	36,30,31,588	100.00%

@ Based on the Reconciliation of Share Capital Audit filed for the December 2025 quarter in terms of Regulation 76 of SEBI (Depositories and Participants) Regulations, 2018:

Sl.	Particulars	Particulars	No. of Equity Shares	No. of Equity Shares
1	Issued Capital of the Company			32,45,34,125
2	Listed Capital of the Company			32,44,99,774
3	Paid upCapital of the Company			32,45,21,588
	Particulars	Number ofEquity Shares		Reason for difference
Reason for difference between Issued Capital and Listed Capital		34,351		o Specifically 19,44,18,898 Equity Shares of Re.1/- each allotted-on 5th May, 2007 (out of32,45,34,125 as on date), pursuant to in-principle approvals, 57,036 shares were originally kept under abeyance, of which 35,222 shares were released between March 2010 and November 2021, leaving 21,814 equity shares currently under abeyance o 12537 equity shares were forfeited on 24/07/2015 (Out of 17093, forfeiture of 4556 share have been annulled up to date)
Reason for difference between Issued Capital and Paid Up Capital		12,537		o 12537 shares were forfeited on 24/07/2015 (Out of 17093, forfeiture of 4556 share have been annulled up to date)
Reason for difference between Listed Capital and Paid Up Capital		21,814		o Specifically 19,44,18,898 Equity Shares of Re.1/- each allotted-on 5th May, 2007 (out of32,45,34,125 as on date), pursuant to in-principle approvals, 57,036 shares were originallykept under abeyance,of

Page 2 of 3

which 35,222 shares were released between March 2010 and November 2021, leaving 21,814 equity shares currently under abeyance

Copy of said report is uploaded on the website of the Company at htps://sparc.life/statutorydisclosures/shareholders-meetng/

There is no change to the proposed size, pricing or structure of the Warrants Issue.

# The above post issue shareholding pattern is presented, assuming full conversion of all the Warrants into equivalent number of equity shares of the Company.

^ 1200 shares are in physical mode, which are pending transfer to Virtuous Finance Private Limited (which amalgamated with Shanghvi Finance Private Limited w.e.f. 23/10/2018) due to court litigation by the seller of such shares. No change in demat holding of Shanghvi Finance Private Limited. This disclosure is to be read with the circular dated Mar 30, 2012, bearing reference no.: SEBI/Cir/ISD/1/2012, issued by SEBI in relation to Exemptions from 100% promoter(s) holding in demat form. Referred circular is as on the date of this EGM Notice is hosted on the website of the SEBI at htps://www.sebi.gov.in/legal/circulars/mar-2012/exemptons-from-100-promoter-sholding-in-demat-form_22461.html

This Corrigendum shall be published in one English language newspaper and one Gujarati language newspaper having wide circulation in the district where the registered office of the Company is situated, namely Financial Express (English) and in Ahmedabad Edition (Gujarati Language) Financial Express on January 30, 2026. The Corrigendum shall also be made available on the websites of the stock exchanges, i.e. BSE and NSE, as well as on the website of the Company at https://sparc.life/statutorydisclosures/shareholders-meeting/. Further, the Corrigendum shall be communicated to the Members through electronic means, in the same manner as the EGM Notice, to ensure adequate dissemination of information prior to the commencement of e-voting.

This Corrigendum shall form an integral part of the EGM Notice.

By Order of the Board

For Sun Pharma Advanced Research Company Limited

Kajal Kiran Damania Digitally signed by Kajal Kiran DamaniaDN: C=IN, O=Personal, PostalCode=400050, S=Maharashtra, SERIALNUMBER=20771e9be78b61091f926f4b91c9856091372c5750bea467c18f3cb41af3da6b, CN=Kajal Kiran DamaniaReason: I am the author of this documentLocation: MahakaliDate: 2026.01.29 18:20:15+05'30'Foxit PDF Editor Version: 2024.3.0 Kajal Damania Company Secretary & Compliance Officer Date: January 29, 2026 Place: Mumbai

Page 3 of 3